Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
05/2005
05/03/2005US6887502 Compositions comprising fat soluble substances in a glassy carbohydrate matrix
04/2005
04/28/2005WO2005037849A1 Process for preparing solidified maltitol and its use in food and pharma products
04/28/2005WO2005037711A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes
04/28/2005WO2005037187A2 High affinity ligands for influenza virus and methods for their production
04/28/2005US20050090655 synthesizing an O-glycan among the glycoprotein-type sugar chains using a saccharide primer in cells
04/28/2005US20050090487 Cardiovascular disorders; antiinflammatory agents
04/28/2005US20050090462 Aminoglycoside antibiotics and methods of using same
04/28/2005US20050090452 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
04/28/2005CA2543158A1 Process for preparing solidified maltitol and its use in food and pharma products
04/28/2005CA2540195A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes
04/27/2005EP1525208A2 Novel difluorinated gem compounds, preparation methods thereof and applications of same
04/27/2005EP1525002A1 Method for the synthesis of anthracycline-peptide conjugates
04/27/2005EP1525001A1 Conjugates of porphyrin compounds with chemotherapeutic agents
04/27/2005EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1
04/26/2005US6884604 Generation of random nucleotide sugar libraries for use in the generation of coumarin and ertyhronilide derivatives; obtain nucleotide sugar, incubate with glycosyltransferase, recover glycosylated product
04/26/2005US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions
04/21/2005WO2005005449A3 Steroid modified solatrioses
04/21/2005US20050085632 Using anion exchange resin and elution wash to sequentially remove phytates and isoflavones from plant extracts; supplementing human food for consumption; food processing
04/21/2005US20050085427 Transfection agents
04/21/2005US20050085413 Dimeric pharmaceutical compounds and their use
04/21/2005US20050084535 Novel calixarene based dispersible colloidal systems in the form of nanoparticles
04/20/2005EP1307446B1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
04/19/2005US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents
04/14/2005WO2005033652A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
04/14/2005WO2005033122A1 Glycerol carbonate glycoside
04/14/2005WO2005033100A1 Novel hypocholesterolemic compounds
04/14/2005WO2005017180A3 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
04/14/2005WO2005007665A8 Lincomycin derivatives possessing antibacterial activity
04/14/2005US20050080042 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease
04/14/2005US20050080022 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like
04/14/2005US20050080020 Hydroxylated indirubin derivatives
04/14/2005CA2840691A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
04/14/2005CA2541822A1 Novel hypocholesterolemic compounds
04/14/2005CA2530789A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
04/13/2005EP1522541A1 Novel hypocholesterolemic compounds
04/13/2005EP1521828A2 Production of polyketides
04/13/2005EP1521762A2 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
04/13/2005EP1521761A2 Treatment of congenital disorders of glycosylation (cdg) using mannose
04/13/2005CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
04/13/2005CN1606446A Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides
04/13/2005CN1606436A Compounds and methods of treating transplant rejection
04/13/2005CN1196708C Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
04/12/2005US6878819 Oligosaccharides or oligosaccharide containing compounds, especially N-acetyl-chitooligosaccharides, which are fucosylated with donar nucleotide sugar containing L-fucose such as guanosine diphosphate-L-fucose
04/12/2005CA2131229C Bisconjugates comprising two saccharides and a spacer
04/07/2005WO2004062590A3 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
04/07/2005US20050075389 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same
04/07/2005US20050075310 Gangliosides with a modified acyl function
04/07/2005US20050075294 E.g., 2-(4-Methoxybenzyl)phenyl beta -D-glucopyranoside; inhibitors of human SGLT2 (Na+/glucose cotransporter 2); prevents reabsorption of excess glucose at the kidney, promotes excreting excess glucose though the urine, and normalizes blood glucose level; hypoglycemic and antidiabetic agent; obesity
04/06/2005EP1520583A2 NKT cell-activating agents containing alpha-glycosylceramides
04/06/2005EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
04/06/2005CN1603331A 9-{2-[bis(pivaloyloxymethoxy) phosphorylmethoxyl]ethyl} adenine glucuronate and its preparation process
04/06/2005CN1603330A Beta-cyclodextrin inclusion composite
04/06/2005CN1195767C Antithrombotic compound
04/06/2005CN1195525C Antitumor agents comprising silicon and nitrogen containing compounds as the principal agent
04/05/2005US6875886 Modified PSMA ligands and uses related thereto
04/05/2005US6875755 Antithrombotic compound
04/05/2005US6875752 Therapy for grampositive bacteria; bactericides
04/05/2005US6875746 Anticancer anthraquinones and method of use thereof
04/05/2005US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
03/2005
03/31/2005WO2005028491A1 Epimeredi glycoside a, the formulation containing thereof and their preparation method
03/31/2005WO2005027828A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
03/31/2005WO2004105688A3 Bactericidal composition and associated method
03/30/2005EP1517692A1 Method and agent for the prevention, inhibition and treatment of sepsis
03/30/2005CN1194982C Structure of phenethyl alcohol glycoside compound and its use
03/29/2005US6872713 Plant extracts
03/29/2005US6872709 Using glycyrrhizin
03/29/2005US6872706 Hypoglycemic agents; antidiabetic agents; dietetics
03/29/2005US6872414 Comprise spontaneous nucleation or seeding; for use as sugar substiture in foods, sweets, and pharmaceuticals
03/29/2005CA2244142C Antifungal compound from hormonema sp.
03/24/2005WO2005026183A1 Beta-fructosyl-l-ascorbic acid and the preparation method thereof
03/24/2005US20050065098 Antidiabetic agents; hypoglycemic agents; dietetics; bioavailability
03/24/2005US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
03/23/2005EP1515934A1 Method for producing c13-alcohol mixtures
03/23/2005EP1515721A1 Ophthalmic compositions for treating ocular hypertension
03/23/2005CN1597690A Enrichment method of rhodiola root glycoside compound
03/23/2005CN1597689A Ledebouriella root glycoside and its preparation and application
03/23/2005CN1597688A Method of preparing alkyl glycoside by narrow leaved oleaster saccharide
03/23/2005CN1596901A Ledebouriella root extract preparation used for treating climacteric syndrome and preparation method
03/23/2005CN1193763C Rhodiola total tanning matter extract and use for preparing medicine for treating senile dementia
03/22/2005US6870048 Process for the preparation of 2'-halo-β-L-arabinofuranosyl nucleosides
03/22/2005US6869974 Pharmaceutical compounds
03/22/2005CA2147629C Novel sphingoglycolipids and the use thereof
03/17/2005US20050059817 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives
03/17/2005US20050059814 Alkylated c-sugars and uses thereof
03/17/2005US20050059614 Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
03/17/2005US20050059612 Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
03/16/2005EP1513942A2 Galactosyl isomalt, method for production and use thereof
03/16/2005EP1513855A1 Fatty acid esters of ethoxylated alkylglucosides
03/16/2005EP0946578B1 Phosphanes, their method of production and use in metal complexes
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1594342A Glycosyl phthalic imidine compounds with anti-inflammatory activity
03/16/2005CN1594341A Fatty acid ester compounds of ginsenoside secondary glycoside compound K and method for preparing same
03/16/2005CN1594340A Process for extraction refining amygdalin
03/16/2005CN1193035C Process for preparation of sphingolipids and sphingolipid derivatives
03/16/2005CN1192992C Method for producing alcohol surfactants and alcohol ether surfactants, products obtained and their use
03/15/2005US6867230 Antibacterial and antiprotozoal agents
03/15/2005US6867198 Agents and methods for the treatment of proliferative diseases
03/10/2005WO2005021565A1 Method of preparing 4-r-substituted 4-demethoxydaunorubicin
03/10/2005WO2005021501A1 Minimally invasive physiological function monitoring agents
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 180